Back

Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Registries and cost of treatment Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
Mr P. Cozzolino (Monza, IT)
Abstract Slides
Presentation thumbnail
Miss M. Lee (Tainan, TW)
Abstract
Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Doctor W. Berger (Nieuwegein, NL)
Abstract
Presentation thumbnail
Doctor K. Szummer (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Registries and cost of treatment

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic
27 August 2021
thumbnail
Congress Presentation
GLORIA-AF: new Phase III data from this innovative registry program.
28 August 2022
thumbnail
Webinar
How to manage elderly patients with atrial fibrillation and multiple comorbidities
12 November 2021
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources